Viridian Therapeutics Shares Jump as REVEAL-1 Phase 3 Hits Primary Endpoint in Thyroid Eye Disease

Viridian Therapeutics (NASDAQ:VRDN) reported top-line results from its REVEAL-1 Phase III clinical trial evaluating ...
Verywell Health on MSN

IV vs. subcutaneous cancer therapies: What’s the difference?

Medically reviewed by Marla Anderson, MD Key Takeaways IV therapy delivers cancer medicine directly into a vein and often ...

Welcome to the Longevity Tourism Boom

By 85, according to the Social Security Administration, it’s more like 10 percent. Death comes quickly.) Soon after the carry-on incident, Scott saw an advert for an experimental gene therapy from a ...

IV drip services are expanding in Central Mass. Do they work?

Laura Lenis receives an IV treatment March 19 at Vita Hydration and Wellness in Worcester. WORCESTER – Laura Lenis looked ...